Navellier & Associates’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $272K | Hold |
2,164
| – | – | 0.03% | 272 |
|
2025
Q1 | $264K | Hold |
2,164
| – | – | 0.04% | 270 |
|
2024
Q4 | $331K | Hold |
2,164
| – | – | 0.04% | 269 |
|
2024
Q3 | $419K | Hold |
2,164
| – | – | 0.06% | 242 |
|
2024
Q2 | $502K | Hold |
2,164
| – | – | 0.06% | 242 |
|
2024
Q1 | $467K | Hold |
2,164
| – | – | 0.06% | 251 |
|
2023
Q4 | $560K | Hold |
2,164
| – | – | 0.08% | 207 |
|
2023
Q3 | $556K | Buy |
+2,164
| New | +$556K | 0.1% | 195 |
|
2016
Q1 | – | Sell |
-3,146
| Closed | -$964K | – | 263 |
|
2015
Q4 | $964K | Sell |
3,146
-1,600
| -34% | -$490K | 0.11% | 88 |
|
2015
Q3 | $1.39M | Sell |
4,746
-71,087
| -94% | -$20.7M | 0.14% | 70 |
|
2015
Q2 | $30.6M | Buy |
75,833
+1,953
| +3% | +$789K | 2.69% | 10 |
|
2015
Q1 | $31.2M | Sell |
73,880
-92,993
| -56% | -$39.3M | 2.83% | 12 |
|
2014
Q4 | $56.6M | Sell |
166,873
-8,596
| -5% | -$2.92M | 2.83% | 10 |
|
2014
Q3 | $58M | Sell |
175,469
-22,304
| -11% | -$7.38M | 2.92% | 10 |
|
2014
Q2 | $62.4M | Sell |
197,773
-15,545
| -7% | -$4.9M | 2.82% | 8 |
|
2014
Q1 | $65.2M | Sell |
213,318
-3,282
| -2% | -$1M | 3.04% | 8 |
|
2013
Q4 | $60.6M | Sell |
216,600
-108,796
| -33% | -$30.4M | 2.73% | 9 |
|
2013
Q3 | $78.3M | Sell |
325,396
-9,044
| -3% | -$2.18M | 2.31% | 2 |
|
2013
Q2 | $72M | Buy |
+334,440
| New | +$72M | 3.43% | 3 |
|